• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 6th March 2017

New Member of the EuroQol Group: OHE’s Dr Yan Feng

OHE’s Yan Feng becomes a member of the EuroQol Research Foundation. Dr Yan Feng, Senior Economist at OHE, has been awarded membership of the EuroQol Research Foundation, the not-for profit research organisation which developed the EQ-5D, a widely used measure of…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Yan-Feng-V1

OHE’s Yan Feng becomes a member of the EuroQol Research Foundation.

Dr Yan Feng, Senior Economist at OHE, has been awarded membership of the EuroQol Research Foundation, the not-for profit research organisation which developed the EQ-5D, a widely used measure of self-reported health.

Dr Feng has been involved in statistical and econometric analysis of EQ-5D data since 2011, working closely with OHE’s Professor Nancy Devlin, Mike Herdman, Koonal Shah and OHE Senior Fellow Professor David Parkin. She has made important contributions to OHE’s research on health outcomes, including both methodological and applied EQ-5D research.

Dr Feng is currently principal investigator on a number of projects including:

  1. Revisiting the Measurement and Valuation of Health (MVH) study: new methods for modelling UK valuations for the EQ-5D-3L, in collaboration with Professor Ben van Hout (University of Sheffield) and Professor Nancy Devlin;
  2. Understanding the relationship between clinical quality of primary care and patient self-reported health on the EQ-5D in England, in collaboration with Professor Hugh Gravelle (University of York) and Professor Nancy Devlin;
  3. Exploring the inconsistent ordering of the EQ-5D-5L value set, in collaboration with Professor Gordon G Liu (Peking University) and Professor Nancy Devlin.

She is also contributing econometric expertise to a wide range of projects, including ‘Anchoring discrete choice experiment values at 0 for the EQ-5D-Y’; ‘Developing an EQ-5D-5L value set for Australia using the EQ-VT protocol’; and ‘New methods for analysing the distribution of EQ-5D observations’. Yan is also leading the work to model an EQ-5D-5L value set for the UK, building on the value set for England (currently under review with a peer review journal).

Professor Nancy Devlin comments, “We are delighted that Yan has been offered membership of the EuroQol Group. This is a well-deserved recognition of the excellent work she has been undertaking on econometric analysis of EQ-5D data over a number of years, and the substantial ongoing programme of work Yan has planned in this area”. 

Yan’s recent publications relating to the EQ-5D include the following:

  • Parkin, D., Devlin, N., Feng, Y., 2016. What determines the shape of an EQ-5D index distribution? (Open access article). Medical Decision Making, 36, pp.941. 
  • Feng, Y., Herdman, M., van Nooten, F., Cleeland, C., Parkin, D., Ikeda, S., Igarashi, A., and Devlin, N. An exploration of differences between Japan and two European countries in the self-reporting and valuation of pain and discomfort on the EQ-5D (under revision with journal).
  • Cole, A., Shah, K., Mulhern, B., Feng, Y., Devlin, N., 2016. Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment (under revision with journal).
  • Feng, Y, Hole, A., Karimi, M., Tsuchiya, A. and van Hout, B., 2016 (these authors are ordered alphabetically).  An exploration of the non-iterative time trade off. Presented at the EuroQol Research Foundation’s 33rd plenary meeting in September 2016.
  • Feng, Y., Devlin, N., Bateman, A., Zamora, B., Parkin, D., 2016. The distribution of the EQ-5D-5L Index in patient populations. OHE Research Paper. London: Office of Health Economics. 
  • Feng, Y., Devlin, N., Liu, G., 2016. Exploring the inconsistent ordering of the EQ-5D-5L value set. Presented at the UK Health Economist Study Group meeting in June 2016.
  • Zamora, B., Parkin, D., Feng, Y., Bateman, A., Herdman, M., Devlin, N., 2017. New methods for analysing the distribution of EQ-5D observations. Presented at the UK Health Economists Study Group meeting in January 2017.
  • Feng, Y., Devlin, N., Herdman, M., 2015. Assessing the health of the general population in England: how do the EQ-5D 3L and 5L versions compare? Health and Quality of life Outcomes, 13, pp.171.
  • Feng, Y., Parkin, D., Devlin, N., 2014. Assessing the performance of the EQ-VAS in the NHS PROMS programme. Quality of Life Research, 23(3), pp.977. 
  • EQ-5D and PROMs
  • Measuring and Valuing Outcomes

Related News

Group 11119
  • News
  • February 2023

Applications open for MSc Fellowship Programme 2023

Read more
Prize event
  • News
  • January 2023

Professor Aidan Hollis wins first £40,000 OHE Policy Innovation Prize

Read more
  • News
  • July 2022

OHE is Leading Research to Develop an EQ-5D ‘Bolt-on’ for Hearing

Read more
MicrosoftTeams-image-6_0
  • News
  • June 2022

OHE’s 60th Anniversary Party – Celebrating Our Achievements and Looking Forward

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!